By proceeding, you agree to our Terms of Use and Privacy Policy.
Global Head, HEOR, HTA & RWE; and Head, Value & Access, Pipeline Franchise
#healtheconomics #outcomesresearch #marketaccess
#NorthAmerica
Charles Makin is a distinguished expert adept at harmonizing rigorous scientific methodology with strategic business insight to craft, showcase, and disseminate the value and real-world efficacy of ph
Department of Pathology
#cancerresearch #machinelearning #transcriptomics #outcomesresearch #mortalityprediction
With an extensive background spanning over 10 years in clinical research, medicine, biomarker development, and machine learning, I am also the founder of Alghorismus, LLC, a data science company. My t
Senior Fellow
#epidemiology #outcomesresearch
Gail R. Wilensky, Ph.D. is an economist and senior fellow at Project HOPE, an international health foundation. She also co-chairs the Bipartisan Policy Center’s initiative on the future of health care
Product Director, Decentralised Trial Technology
#outcomesresearch
#Europe
Dr. Karl McEvoy has over a decade of industry experience in both the vendor and sponsor sides. His clinical trial experience spans from set-up to delivery across all phases in a wide variety of diseas
Director, Medical Affairs Operations
#Northamerica
Maria Vassilakis is currently working as Director, Medical Affairs Operations at Mirati Therapeutics
Head, Market Access Scientific and External Strategy
#economicmodeling #outcomesresearch #strategicthinking
Silas Martin is the Senior Director leading Market Access Scientific and External Strategy for Janssen Scientific Affairs. His team shapes scientific strategy, develops policy evidence, and engages w
Sr. Director, Head of Pharmacoepidemiology, Specialty Care
#biostatistics #pharmacoepidemiology #outcomesresearch
William Blumentals heads the pharmacoepidemiology group for Specialty Care at Sanofi and is based in Cambridge, MA. He has spent 20 years supporting and leading epidemiology teams in small and large p